Michal Piják, MD - Personalised Evolutionary Nutrition,
VYZERÁ TO S REMDESIVIROM ZLE, VEĽMI…
VYZERÁ TO S REMDESIVIROM ZLE, VEĽMI…
total of 1062 patients underwent randomization (with 541 assigned to remdesivir and 521 to placebo). Those who received…
Reporte…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Final Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Final Report
"data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid…
Remdesivir wird in der Presse nicht immer als ein wirksames COVID-19-Medikament kommuniziert. Jetzt zeigt der abschließende…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Final Report
"Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral…
Résultats finaux de l’étude internationale (ACTT-1) sur le remdésivir montrant une diminution du délai de récupération chez les…
"The Kaplan–Meier estimates of mortality were 6.7% with remdesivir and 11.9% with placebo by day 15 and 11.4% with remdesivir…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Final Report
Concluzii pe baza datelor din acest studiu: Remdesivir ameliorează boala la pacienții gravi (care primesc oxigen), dar nu…
Remdesivir demostró disminuir el tiempo de recuperación de pacientes Hospitalizados por #COVID19: https://www.nejm.org/doi/pdf/10…
COVID-19 NEWS: Today the The New England Journal of Medicine published a final report on NIAID’s Adaptive COVID-19 Treatment…
We are so excited to share some research that IHB alumnus Matthew Eckles (Bachelor of Science in Integrated Human Biology '17…
JAMA har publicerat en ganska omfattande review-artikel som går igenom patofysiologi, transmission, diagnostik, klinisk…
#NoticiasCienciorama Dexametasona contra COVID-19 ¿panacea o nah? Noticia de Dannia Colín Castelán #COVID19 #Dexametasona #pa…
https://www.nejm.org/doi/10.1056/NEJMoa2007764
#covid19 #remdesivir #nejm A total of 1063 patients underwent randomization. The data and safety monitoring board recommended…
COVID-19に対するレミデシビルの効果 Adaptive Covid-19 Treatment Trial (ACTT-1)。 Beigel JH et al. Remdesivir for the Treatment of Covid-19 …
Étude randomisée, à double insu, comparant le remdésivir au placebo chez les patients atteints de Covid-19 ayant des signes d’att…
Das Virustatikum Remdesivir, das in Europa kurz vor der Zulassung steht, erzielt offenbar die besten Ergebnisse bei Patienten…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Remdesivir stoppt die Vermehrung von SARS-CoV (es hemmt die virale RNA-Polymerase). Bei Covid-19-Infektionen ist es wirksam…
Remdesivir for the Treatment of Covid-19 — Preliminary…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
And some interesting news about remdesivir... https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Remdesivir para el tratamiento de Covid-19. Reporte…
Science works, as opposed to trump's unwavering beliefs in whatever, until they morph. "We conducted a double-blind, randomized…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
Para saborear sem pressa... E também não perguntem nossa opinião por ora. Particularmente para a realidade brasileira, queremos…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764… COVID-19に対するレムデシビルの多国間多施設 RCT (ACTT-1 )の速報が論文化されてNEJMに掲載されました. ・無性症/軽症(上気道…
Remdesivir for the Treatment of Covid-19 — Preliminary…
Latest on Remdesivir: 1. These preliminary findings support the use of remdesivir for patients who are hospitalized with Covid…
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=RP 드디어 기다리던 Remdesivir trial결과가 출판되었습니다. 기대반 실망반. HFNC 이상의…
Un total de 1063 pacientes fueron aleatorizados. La junta de monitoreo de datos y seguridad recomendó el cegamiento temprano de…
#瑞德西韋可以縮短武漢肺炎康復時間 從15天縮短至11天(中位數) 美國一項跨國研究,因發現瑞德西韋會縮短康復時間,而「提早解盲」發表在NEJM《新英格蘭醫學期刊》 #研究名稱: Adaptive Covid-19 Treatment Trial (AC…
This is why you HAVE to wait for actual DATA. Remember even Tony Fauci was giving this interim result a big "hurrah" in the…
The preliminary data published in @NEJM showed that #Remdesivir is effective for #covid19 patients who have pneumonia like…
Original Article from The New England Journal of Medicine — Remdesivir for the Treatment of Covid-19 — Preliminary Report
In this randomized, double-blind trial in 1063 adults hospitalized with Covid-19, a 10-day course of intravenous remdesivir was…